Last reviewed · How we verify

Clopidogrel and Omeprazole

Takeda · Phase 1 active Small molecule

Clopidogrel and Omeprazole is a Small molecule drug developed by Takeda. It is currently in Phase 1 development. Also known as: Plavix.

At a glance

Generic nameClopidogrel and Omeprazole
Also known asPlavix
SponsorTakeda
ModalitySmall molecule
PhasePhase 1

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Key clinical trials

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

SourceUsed for
ClinicalTrials.govTrial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

Frequently asked questions about Clopidogrel and Omeprazole

What is Clopidogrel and Omeprazole?

Clopidogrel and Omeprazole is a Small molecule drug developed by Takeda.

Who makes Clopidogrel and Omeprazole?

Clopidogrel and Omeprazole is developed by Takeda (see full Takeda pipeline at /company/takeda).

Is Clopidogrel and Omeprazole also known as anything else?

Clopidogrel and Omeprazole is also known as Plavix.

What development phase is Clopidogrel and Omeprazole in?

Clopidogrel and Omeprazole is in Phase 1.

Related